Go Pro
→ A simple options setup that cuts through the noise (From TradeWins) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$86.03
+0.9%		$74.67
$32.21
▼
$170.87
$2.57B1.99933,441 shs4,109 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-0.85%+9.20%+39.04%-31.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$86.03
+0.9%		$74.67
$32.21
▼
$170.87
$2.57B1.99933,441 shs4,109 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.00%-0.85%+9.20%+39.04%-31.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.89
Moderate Buy$89.574.11% Upside

Current Analyst Ratings Breakdown

Latest WGS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D)
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$75.00 ➝ $90.00
8/4/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$90.00
7/28/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/15/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
6/29/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$70.00 ➝ $74.00
6/29/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
6/23/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$50.00 ➝ $63.00
(Data available from 9/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M6.00$2.31 per share37.20$10.54 per share8.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$3.64N/A74.81N/A-23.41%4.12%2.26%10/27/2026 (Estimated)

Latest WGS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$0.1879$0.01+$0.1979-$0.60$111.01 million$114.44 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.40
3.30
3.06

Institutional Ownership

CompanyInstitutional Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
25.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.82 million22.32 millionOptionable

Recent News About These Companies

Insider Selling: GeneDx (NASDAQ:WGS) CEO Sells $310,940.24 in Stock
September 14 at 4:22 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31022899
GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 1,285 Shares of Stock
September 12 at 6:52 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-wgs-insider-buying-and-selling-2026-09-12/
Kevin Feeley Sells 1,285 Shares of GeneDx (NASDAQ:WGS) Stock
September 11 at 5:21 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-kevin-feeley-sells-1285-shares-of-genedx-nasdaq-wgs-stock-2026-09-11/
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 3,692 Shares of Stock
September 11 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-genedx-nasdaq-wgs-ceo-katherine-stueland-sells-3692-shares-of-stock-2026-09-11/
First Light Asset Management LLC Has $53.82 Million Position in GeneDx Holdings Corp. $WGS
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-first-light-asset-management-llc-has-5382-million-position-in-genedx-holdings-corp-wgs-2026-09-10/
3 Promising Genomics Stocks in the Spotlight in 2026
September 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2986615/3-promising-genomics-stocks-in-the-spotlight-in-2026?cid=cs-stocknewsapi-ft-genomics_&_synthetic_biology-2986615
Bank of New York Mellon Corp Invests $4.26 Million in GeneDx Holdings Corp. $WGS
September 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-invests-426-million-in-genedx-holdings-corp-wgs-2026-09-06/
GeneDx (NASDAQ:WGS) Upgraded to "Strong-Buy" at Zacks Research
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-genedx-nasdaq-wgs-upgraded-to-strong-buy-at-zacks-research-2026-08-28/
GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors
August 26, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9055136/genedx-holdings-corp-wgs-shares-surge-33-what-gf-score-of-65-tells-investors
Royal Bank of Canada Has $571,000 Stock Holdings in GeneDx Holdings Corp. $WGS
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-has-571000-stock-holdings-in-genedx-holdings-corp-wgs-2026-08-25/
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
August 24, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genedx-announces-transformative-study-supporting-123000368.html
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children's
August 24, 2026  |  markets.ft.comhttps://markets.ft.com/data/announce/detail?dockey=600-202608240830BIZWIRE_USPRX____20260824_BW639564-1
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of "Moderate Buy" from Analysts
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/genedx-holdings-corp-nasdaqwgs-receives-average-rating-of-moderate-buy-from-analysts-2026-08-22/
GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-genedx-holdings-corp-wgs-shares-purchased-by-bank-of-america-corp-de-2026-08-21/
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2977143/can-genedx-holdings-wgs-run-higher-on-rising-earnings-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_8-2977143
GeneDx: Why I Think The Worst Is Behind The Business
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937771-genedx-why-i-think-the-worst-is-behind-the-business
GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
August 12, 2026  |  insurancenewsnet.comI
GeneDx (WGS) Q2 2026 Earnings Call Transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/genedx-wgs-q2-2026-earnings-014646426.html
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Value Says Overvalued
August 11, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9026297/is-genedx-holdings-corp-wgs-overvalued-after-51-rally-gf-value-says-overvalued
Piper Sandler Sticks to Its Buy Rating for GeneDx Holdings (WGS)
August 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/WGS/pressreleases/3664670/piper-sandler-sticks-to-its-buy-rating-for-genedx-holdings-wgs/
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone
August 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/genedx-holdings-wgs-18-4-011200620.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

GeneDx stock logo

GeneDx NASDAQ:WGS

$86.03 +0.77 (+0.91%)
As of 09:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas